HIV: A therapeutic advance for resource-limited settings
Monday, May 29, 2017 - 09:32
in Health & Medicine
A clinical trial running in parallel in three countries in sub-Saharan Africa, shows that dual therapy with lamivudine and a boosted protease inhibitor is effective as second-line treatment in patients infected by HIV with multiple mutations. Such treatment deescalation will reduce costs, side effects, and the need for virological monitoring of patients.